Dottikon ES
Script error: No such module "AfC submission catcheck".
 | |
Native name | Dottikon ES Holding AG (abbreviation: Dottikon Exclusive Synthesis) |
|---|---|
| Public | |
| ISIN | 🆔 |
| Founded 📆 | 1913 |
| Founder 👔 | |
| Headquarters 🏙️ | , , |
Area served 🗺️ | |
Key people | Markus Blocher (CEO and Chairman) |
| Revenue🤑 | CHF 251.9 million (2020/21) |
| Members | |
Number of employees | 665 |
| 🌐 Website | www |
| 📇 Address | |
| 📞 telephone | |
Dottikon ES (Legally: Dottikon ES Holding AG[1][2]) is a Swiss multinational corporation founded in 1913 that is specialized in chemical reactions and develops and produces chemicals, intermediate goods and active exclusive ingredients for the chemical, biotechnology and pharmaceutical industries. Formerly belonging to EMS-Chemie (independent since 2002), Dottikon ES has approximately 665 employees and had an annual net turnover of 251.9 million Swiss Francs (2020/21) as well as a net profit of 59.3 million Swiss Francs.[3] Since 2005, Dottikon ES has been listed at SIX Swiss Exchange.[4][5]
References[edit]
- ↑ "Dottikon Es Holding AG - Company Profile and News". Bloomberg.com. Retrieved 2023-03-18.
- ↑ "DOTTIKON ES HOLDING AG in Dottikon". Moneyhouse (in Deutsch). Retrieved 2023-03-18.
- ↑ Public annual reports
- ↑ "DOTTIKON ES N Stock Price & Performance | DESN". SIX. Retrieved 2023-03-18.
- ↑ "Schweizer Firmen drängen auf den Kapitalmarkt". DER STANDARD (in Deutsch). Retrieved 2023-03-18.
External links[edit]
This article "Dottikon ES" is from Wikipedia. The list of its authors can be seen in its historical and/or the page Edithistory:Dottikon ES. Articles copied from Draft Namespace on Wikipedia could be seen on the Draft Namespace of Wikipedia and not main one.
